UroGen Pharma Ltd. (FRA:UR8)
Germany · Delayed Price · Currency is EUR 18.30
-0.50 (-2.66%)
At close: Dec 19, 2025
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of €910.78 million as of December 19, 2025. Its market cap has increased by 82.41% in one year.
Market Cap
910.78M
Enterprise Value
912.94M
Revenue
82.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€18.30
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from 152.95M to 910.78M, an increase of 495.49%. That is a compound annual growth rate of 22.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 910.78M | 109.81% |
| Dec 31, 2024 | 434.10M | 3.64% |
| Dec 29, 2023 | 418.87M | 118.57% |
| Dec 30, 2022 | 191.64M | 2.22% |
| Dec 31, 2021 | 187.48M | -42.39% |
| Dec 31, 2020 | 325.46M | -47.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |